The serotonergic and noradrenergic systems of the hippocampus: Their interactions and the effects of antidepressant treatments

Brain Research Reviews

Volumn 23, Issue 3, 1997, Pages 145-195

  Mongeau, R ^a,b   Blier, P ^a   De Montigny, C ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

antidepressant drug; depression; electroconvulsive shocks treatment; hippocampal formation; locus coeruleus; noradrenaline; raphe nucleus; serotonin

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIDEPRESSANT AGENT; BUSPIRONE; GEPIRONE; IPSAPIRONE; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TANDOSPIRONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BEHAVIOR; DEPRESSION; ELECTROCONVULSIVE THERAPY; ELECTROPHYSIOLOGY; EMOTION; HIPPOCAMPUS; LOCUS CERULEUS; MEMORY; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAPHE NUCLEUS; REVIEW; SEROTONINERGIC SYSTEM;

ANIMALS; ANTIDEPRESSIVE AGENTS; BIOGENIC MONOAMINES; DEPRESSION; HIPPOCAMPUS; HUMANS; NEURAL PATHWAYS; NEURONS; NOREPINEPHRINE; SEROTONIN;

EID: 0030993317     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(96)00017-3     Document Type: Review

References (500)

1. Abercrombie, E.D., Keller, R.W. and Zigmond, M.J., Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioral studies, Neuroscience, 27 (1988) 897-904.
2. Aghajanian, G.K., Mescaline and LSD facilitate the activation of locus coeruleus neurons by peripheral stimuli, Brain Res., 186 (1980) 492-498.
3. Aghajanian, G.K. and Haigler, H.J., L-Tryptophan as a selective histochemical marker for serotonergic neurons in single-cell recording studies, Brain Res., 81 (1974) 364-372.
4. Aghajanian, G.K. and Lakoski, J.M., Hyperpolarisation of serotonergic neurons by serotonin and LSD: studies in brain slices showing increased potassium conductance, Brain Res., 305 (1984) 181-185.
5. Aghajanian, G.K., Sprouse, J.S. and Rasmussen, K., Physiology of the midbrain serotonin system. In H.Y. Meltzer (Ed.), Psychopharmacology: The Third Generation of Progress, Raven Press, Ne York, 1987, pp. 141-149.
6. 2-agonists in locus coeruleus neurons, Brain Res., 371 (1986) 390-394.
7. 2 and opiate effector mechanisms in the locus coeruleus: intracellular studies in brain slices, Neuropharmacology, 26 (1987) 793-799.
8. 2-adrenoceptors in brain slices, Naunyn-Schmiedeberg's Arch. Pharmacol., 345 (1992) 402-409.
9. 2-adrenoceptor mediated effects on noradrenaline release, Naunyn-Schmiedeberg's Arch. Pharmacol., 333 (1986) 104-109.
10. 2-adrenoceptor mediated effects on noradrenaline release, Naunyn-Schmiedeberg's Arch. Pharmacol., 331 (1985) 235-239.
11. 2-adrenoceptor-coupled regulation of electrically evoked noradrenaline release in hippocampus, Naunyn-Schmiedeberg's Arch. Pharmacol., 347 (1993) 14-20.
12. Alreja, M. and Aghajanian, G.K., Pacemaker activity of locus coeruleus neurons: whole cell recordings in brain slices show dependence on cAMP and protein kinase A, Brain Res., 556 (1991) 339-343.
13. Anderson, C., Pasquier, D., Forbes, W. and Morgane, P., Locus coeruleus-to-dorsal raphe input examined by electrophysiological and morphological methods, Brain Res. Bull., 2 (1977) 209-221.
14. 1A receptors in the rat hippocampus and cortex, Drug Dev. Res., 26 (1992) 275-286.
15. 2-adrenoceptor-induced hyperpolarizations of locus ceruleus neurons in brain slices: reversal by cyclic adenosine 3′:5′-monophosphate analogues, J. Neurosci., 5 (1985) 2359-2364.
16. 4 like receptors mediate the slow excitatory response to serotonin in the rat hippocampus, J. Pharmacol. Exp. Ther., 257 (1991) 930-937.
17. Andrade, R. and Nicoll, R.A., Pharmacologically distinct actions of serotonin on single pyramidal neurones of the rat hippocampus recorded in vitro, J. Physiol., 394 (1987) 99-124.
18. Archer, T., Jonsson, G., Minor, B.G. and Post, C., Noradrenergic-serotonergic interactions and nociception in the rat, Eur.J. Pharmacol., 120 (1986) 295-307.
19. Asnis, G.M., Wetzler, S., Sanderson, W.C., Kahn, R.S. and van Praag, H.M., Functional interrelationship of serotonin and norepinephrine: cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal control subjects, Psychiatry Res., 43 (1992) 65-76.
20. Aston-Jones, G. and Bloom, F.E., Activity of NA containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep waking cycle, J. Neurosci., 1 (1981) 876-886.
21. Aston-Jones, G., Ennis, M., Pieribone, W.A., Nickell, W.T. and Shipley, M.T., The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network, Science, 234 (1986) 734-737.
22. Azmitia, E.C. and Segal, M., An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat, J. Comp. Neurol., 179 (1978) 641-667.
23. Baraban, J.M. and Aghajanian, G.K., Suppression of serotonergic neuronal firing by α-adrenoceptor antagonists: evidence against GABA mediation, Eur. J. Pharmacol., 66 (1980) 287-294.
24. Baraban, J.M. and Aghajanian, G.K., Suppression of firing activity of 5-HT neurons in the dorsal raphe by α-adrenoceptor antagonists, Neuropharmacology, 19 (1980) 355-363.
25. Baraban, J.M. and Aghajanian, G.K., Noradrenergic innervation of serotonergic neurons in the dorsal raphe: demonstration by electron microscopic autoradiography, Brain Res., 204 (1981) 1-11.
26. Baraban, J.M., Wang, R.Y. and Aghajanian, G.K., Reserpine suppression of dorsal raphe neuronal firing: mediation by adrenergic system, Eur. J. Pharmacol., 52 (1978) 27-36.
27. Barbaccia, M.L., Brunello, N., Chuang, D.M. and Costa, E., On the mode of action of imipramine: relationship between serotonergic axon terminal function and down-regulation of β-adrenergic receptors, Neuropharmacology, 22 (1983) 373-383.
28. Barbaccia, M.L., Gandolfi, O., Chuang, D.-M. and Costa, E., Modulation of neuronal serotonin uptake by a putative endogenous ligand of imipramine recognition sites, Proc. Natl. Acad. Sci. USA, 80 (1983) 5134-5138.
29. 2-adrenoceptors in the rat brain, Mol. Pharmacol., 42 (1992) 846-855.
30. 3H]nisoxetine autoradiography, Brain Res., 582 (1992) 208-214.
31. Baumann, P.A. and Waldmeier, P.C., Further evidence for negative feedback control of serotonin release in the central nervous system, Naunyn-Schmiedeberg's Arch. Pharmacol., 317 (1981) 36-43.
32. Beck, S.G., Clarke, W.P. and Goldfard, J., Spiperone differentiates multiple 5-hydroxytryptamine responses in rat hippocampal slices in vitro, Eur. J. Pharmacol., 116 (1985) 195-197.
33. Beck, S.G. and Goldfarb, J., Serotonin produces a reversible concentration dependent decrease of population spikes in rat hippocampal slices, Life Sci., 36 (1985) 557-563.
34. Beck, S.G. and Halloran, P.M., Imipramine alters beta-adrenergic, but not serotonergic mediated responses in rat hippocampal pyramidal cells, Brain Res., 504 (1989) 72-81.
35. 3H-5-HT release after noradrenergic denervation with DSP4, Eur. J. Pharmacol., 119 (1985) 131-133.
36. 1-adrenoceptor effect in hippocampal slices, Eur. J. Pharmacol., 166 (1989) 183-191.
37. Bijak, M. and Misgeld, U., Adrenergic modulation of hilar neuron activity and granule cell inhibition in the guinea-pig hippocampal slice, Neuroscience, 67 (1995) 541-550.
38. 1 neurons to serotonin ex vivo, Pol. J. Pharmacol., 46 (1994) 163-167.
39. Blandina, P., Goldfarb, J., Walcott, J. and Green, J.P., Serotonergic modulation of the release of endogenous norepinephrine from rat hypothalamic slices, J. Pharmacol. Exp.Ther., 256 (1991) 341-347.
40. Blier, P., Terminal serotonin autoreceptor function in the rat hippocampus is not modified by pertussis and cholera toxins, Naunyn-Schmiedeberg's Arch. Pharmacol., 344 (1991) 160-166.
41. Blier, P. and Bouchard, C., Effect of repeated electroconvulsive shocks on serotonergic neurons, Eur. J. Pharmacol., 211 (1992) 365-373.
42. 3 receptor which modulates the release of 5-HT in the guinea-pig brain, Br. J. Pharmacol., 108 (1993) 13-23.
43. Blier, P. and Bouchard, C., Modulation of 5-HT release in the guinea pig brain following long-term administration of antidepressant drugs, Br. J. Pharmacol., 113 (1994) 485.
44. Blier, P., Chaput, Y. and de Montigny, C., Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain, Naunyn-Schmiedeberg's Arch. Pharmacol., 337 (1988) 246-254.
45. Blier, P., Curet, O., Chaput, Y. and de Montigny, C., Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine. II. Effects of acute administration of 1-PP and long-term administration of tandospirone on noradrenergic neurotransmission, Neuropharmacology, 7 (1991) 691-701.
46. Blier, P. and de Montigny, C., Effect of chronic tricyclic antidepressant treatment on the serotonergic autoreceptor: a microiontophoretic study in the rat, Naunyn-Schmiedeberg's Arch. Pharmacol., 314 (1980) 123-128.
47. Blier, P. and de Montigny, C., Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat, J. Neurosci., 3 (1983) 1270-1278.
48. Blier, P. and de Montigny, C., Short-term lithium administration enhances serotonergic neurotransmission: electrophysiological evidence in the rat CNS, Eur. J. Pharmacol., 113 (1985) 69-77.
49. Blier, P. and de Montigny, C., Serotonergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors, Neuroscience, 16 (1985) 949-955.
50. Blier, P. and de Montigny, C., Antidepressant monoamine oxidase inhibitors enhance serotonin but not norepinephrine neurotransmission. In Dahl Gram Paul and Potter (Eds.), Clinical Pharmacology in Psychiatry, Springer-Verlag, Berlin, 1987.
51. 1A agonist gepirone: electrophysiological studies in the rat brain, Synapse, 1 (1987) 470-480.
52. Blier, P. and de Montigny, C., Differential effect of gepirone on presynaptic and postsynaptic serotonin receptors: single-cell recording studies, J. Clin. Psychopharmacol., 10 (1990) 13S-20S.
53. Blier, P., de Montigny, C. and Azzaro, A., Effect of repeated amiflamine administration on serotonergic and noradrenergic neurotransmission: electrophysiological studies in the rat CNS, Naunyn-Schmiedeberg's Arch. Pharmacol., 334 (1986) 253-260.
54. Blier, P., de Montigny, C. and Azzaro, A., Modification of serotonergic and noradrenergic neurotransmissions by repeated administration of monoamine oxidase inhibitors: electrophysiological studies in the rat central nervous system, J. Pharmacol. Exp. Ther., 237 (1986) 987-994.
55. Blier, P., de Montigny, C. and Chaput, Y., Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression, J. Clin. Psychopharmacol., 1 (1987) 24S-35S.
56. Blier, P., de Montigny, C. and Chaput, Y., A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence, J. Clin. Psychiatry, 51 Suppl (1990) 14-20.
57. Blier, P., de Montigny, C. and Tardif, D., Effects of the two antidepressant drugs mianserin and indalpine on the serotonergic system: single-cell studies in the rat, Psychopharmacology, 84 (1984) 242-249.
58. 2-adrenergic heteroreceptors in the rat hypothalamus, J. Pharmacol. Exp. Ther., 254 (1990) 236-244.
59. 1A receptors in the dorsal raphe and hippocampus: II. Effect of pertussis and cholera toxins, J. Pharmacol. Exp. Ther., 265 (1993) 16-22.
60. 1A receptors in the dorsal raphe and hippocampus: effect of spiperone, J. Pharmacol. Exp. Ther., 265 (1993) 7-15.
61. 3H]S-HT release in the guinea pig hypothalamus are not autoreceptors, Synapse, 15 (1993) 143-148.
62. 1 receptor agonists and p-chloroamphetamine, Synapse, 5 (1990) 120-133.
63. Blier, P., Steinberg, S., Chaput, Y. and de Montigny, C., Electrophysiological assessment of putative antagonists of 5-hydroxytryptamine receptors: a single-cell study in the rat dorsal raphe nucleus, Can. J. Physiol. Pharmacol., 67 (1989) 98-105.
64. Bliss, T.V., Goddard, G.V. and Riives, M., Reduction of long-term potentiation in the dentate gyrus of the rat following selective depletion of monoamines, J. Physiol., 334 (1983) 475-491.
65. 1B receptors, J. Pharmacol. Exp. Ther., 250 (1989) 37-43.
66. 1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats, Psychopharmacology, 117 (1995) 358-363.
67. 2-adrenoceptors to the imidazoline preferring receptors, Fund. Clin. Pharmacol., 6 Suppl. 1 (1992) 15s-21s.
68. Bouthillier, A., Blier, P. and de Montigny, C., Flerobuterol, a beta-adrenoceptor agonist, enhances serotonergic neurotransmission: an electrophysiological study in the rat brain, Psychopharmacology, 103 (1991) 357-365.
69. 3H-norepinephrine release from synaptosomes is blocked by depolarization, J. Pharmacol. Exp. Ther., 253 (1990) 1063-1069.
70. Brady, L.S., Gold, P.W., Herkenham, M., Lynn, A.B. and Whitfield Jr., H.J., The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: therapeutic implications, Brain Res., 572 (1992) 117-125.
71. Brady, L.S., Whitfield Jr., H.J., Fox, R.J., Gold, P.W. and Herkenham, M., Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications, J. Clin. Invest., 87 (1991) 831-837.
72. Bricca, G., Dontenwill, M., Molines, A., Feldman, J., Belcourt, A. and Bousquet, P., The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem, Eur. J. Pharmacol., 150 (1988) 401-402.
73. 1A agonists uncouple noradrenergic somatodendritic impulse flow and terminal release, Brain Res. Bull., 27 (1991) 693-696.
74. Brown, T.H. and Zador, A.M., Hippocampus. In G.M. Sherperd (Ed.), The Synaptic Organization of the Brain, Oxford University Press, New York, 1990, pp. 346-388.
75. Brunello, N., Barbaccia, M.L., Chuang, D.M. and Costa, E., Down-regulation of β-adrenergic receptors following repeated injections of desmethylimipramine: permissive role of serotonergic axons, Neuropharmacology, 21 (1982) 1145-1149.
76. Burgard, E.C., Decker, G. and Sarvey, J.M., NMDA receptor antagonists block norepinephrine-induced long-lasting potentiation and long-term potentiation in rat dentate gyrus, Brain Res., 482 (1989) 351-355.
77. 2 receptors and the abundancies of 5-HT receptor and transporter mRNA in the cortex, hippocampus and dorsal raphe of three strains of rat, Brain Res., 638 (1994) 311-324.
78. Buzsáki, G., Two-stage model of memory trace formation: a role for 'noisy' brain states, Neuroscience, 31 (1989) 551-570.
79. Cadogan, A.K., Kendall, D.A., Fink, H. and Marsden, C.A., Social interaction increases 5-HT release and cAMP efflux in the rat ventral hippocampus in vivo, Behav. Pharmacol., 5 (1994) 299-305.
80. Cage, F.H., Björklund, A. and Stenevi, U., Reinnervation of the partially deafferented hippocampus by compensatory collateral sprouting from spared cholinergic and noradrenergic afferents, Brain Res., 268 (1983) 27-37.
81. 3H]noradrenaline release to calcium but not to clonidine, Brain Res., 372 (1986) 253-259.
82. 1A receptors causes amnesia andd anxiolytic-like but not antidepressant-like effects in the rat, Eur. J. Pharmacol., 234 (1993) 215-221.
83. Cedarbaum, J.M. and Aghajanian, G.K., Noradrenergic neurons of the locus coeruleus: inhibition by epinephrine and activation by α-antagonist piperoxane, Brain Res., 112 (1976) 413-419.
84. Cedarbaum, J.M. and Aghajanian, G.K., Afferent projections to the rat locus coeruleus as determined by a retrograde technique, J. Comp. Neurol., 178 (1978) 1-16.
85. Cerrito, F. and Raiteri, M., Supersensitivity of central noradrenergic presynaptic autoreceptors following chronic treatment with the antidepressant mianserin, Eur. J. Pharmacol., 70 (1981) 425-426.
86. Chaput, Y., Araneda, R.C. and Andrade, R., Pharmacological and functional analysis of a novel serotonin receptor in the rat hippocampus, Eur. J. Pharmacol., 182 (1990) 441-456.
87. Chaput, Y., Blier, P. and de Montigny, C., In vivo electrophysiological evidence for the regulatory role of autoreceptors on serotonergic terminals, J. Neurosci., 6 (1986) 2796-2801.
88. 1 receptor antagonist, BMY 7378, on 5-hydroxytryptamine neurotransmission: electrophysiological studies in the rat central nervous system, J. Pharmacol. Exp. Ther., 246 (1988) 359-370.
89. Chaput, Y., de Montigny, C. and Blier, P., Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain, Naunyn-Schmiedeberg's Arch. Pharmacol., 333 (1986) 342-348.
90. Chaput, Y., de Montigny, C. and Blier, P., Presynaptic and post-synaptic modifications of the serotonin system by long-term administration of antidepressant treatments: an in vivo electrophysiologic study in the rat, Neuropsychopharmacology, 5 (1991) 219-229.
91. 1A receptors, Comp. Rend. Acad. Sci., 312 (1991) 421-426.
92. 1 binding sites in depressed suicides, Psychopharmacology, 102 (1990) 544-548.
93. 2 agonists augments γ-aminobutyric acid and excitatory amino acid inputs to noradrenergic locus coeruleus neurons, Neuroscience, 54 (1993) 409-420.
94. Clarke, W.P., De Vivo, M., Beck, S.G., Maayani, S. and Goldfarb, J., Serotonin decreases population spike amplitude in hippocampal cells through a pertussis toxin substrate, Brain Res., 410 (1987) 357-361.
95. Cohen, R.M., Ebsstein, R.P., Daly, J.W. and Murphy, D.L., Chronic effects of a monoamine oxidase inhibiting antidepressant: decrease in functional α-adrenergic autoreceptors precede the decrease in norepinephrine-stimulated cyclic adenosine 3′,5′-monophosphate systems in rat brain, J. Neurosci., 2 (1982) 1588-1595.
96. Colino, A. and Halliwell, J.V., 8-OH-DPAT is a strong antagonist of 5-HT action in rat hippocampus, Eur. J. Pharmacol., 130 (1986) 151-152.
97. 1 neurons by serotonin, Nature, 328 (1987) 73-77.
98. Conrad, L.C.A., Leonard, C.M. and Pfaff, D.W., Connections of the median and dorsal raphe nuclei in the rat: an autoradiographic and degeneration study, J. Comp. Neurol., 156 (1974) 179-206.
99. 1 region of rat hippocampal slices, Neuroscience, 46 (1992) 511-518.
100. Cowen, P.J., Grahame-Smith, D.G., Green, A.R. and Heal, D.J., β-Adrenoceptor agonits enhance 5-hydroxytryptamine-mediated behavioral responses, Br. J. Pharmacol., 76 (1982) 265-270.
101. Curet, O. and de Montigny, C., Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. I. Receptors mediating the effect of microiontophoretically applied norepinephrine, Brain Res., 475 (1988) 35-46.
102. Curet, O. and de Montigny, C., Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. II. Receptors mediating the effect of synaptically released norepinephrine, Brain Res., 475 (1988) 47-57.
103. 2-adrenergic autoreceptors, Brain Res., 499 (1989) 18-26.
104. Curet, O., de Montigny, C. and Blier, P., Effect of desipramine and amphetamine on noradrenergic neurotransmission: electrophysiological studies in the rat brain, Eur. J. Pharmacol., 221 (1992) 59-70.
105. 2-adrenoceptors in the regulation of norepinephrine metabolism in the rat brain, J. Pharmacol. Exp. Ther., 240 (1987) 327-336.
106. Curtis, A.L. and Valentine, R.J., Acute and chronic effects of the atypical antidepressant, mianserin on brain noradrenergic neurons, Psychopharmacology, 103 (1991) 330-338.
107. Dahl, D. and Sarvey, J.M., Norepinephrine induces pathway- specific long-lasting potentiation and depression in the hippocampal dentate gyrus, Proc. Natl. Acad. Sci. USA, 86 (1989) 4776-4780.
108. Dahl, D. and Winson, J., Action of norepinephrine in the dentate gyrus. I. Stimulation of locus coeruleus, Exp. Brain Res., 59 (1985) 491-496.
109. de Jonghe, F., Ravelli, D.P. and Tuynman-Qua, H., A randomized, double-blind study of fluoxetine and maprotiline in the treatment of major depression, Pharmacopsychiatry, 24 (1991) 62-67.
110. de Montigny, C., Electroconvulsive shock treatments enhance responsiveness of forebrain neurons to serotonin, J. Pharmacol. Exp. Ther., 228 (1984) 230-234.
111. de Montigny, C. and Aghajanian, G.K., Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin, Science, 202 (1978) 1303-1306.
112. de Montigny, C., Blier, P., Caille, G. and Kouassi, E., Pre- and postsynaptic effect of zimelidine and norzimelidine on the serotonergic system: single cells study in the rat, Acta Psychiatry Scand., 63 suppl. 290 (1981) 79-90.
113. 1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes, J. Pharmacol. Exp. Ther., 238 (1986) 248-253.
114. Deakin, J.F., Graeff, F.G. and Guimaraes, F., 5-HT receptor subtypes and the modulation of aversion. In C. Marsden and D.J. Heal (Eds.), Central Serotonin Receptors and Psychotropic Drugs, Blackwell, London, 1992, pp. 147-174.
115. Deakin, J.F.W., 5-HT receptor subtypes in depression. In P. Beram A.R. Cools and T. Archer (Eds.), Behavioural Pharmacology of 5-HT, Hillsdale, NJ, 1989, pp. 179-204.
116. 2-adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat, J. Pharmacol. Exp. Ther., 241 (1987) 642-649.
117. 3H]norepinephrine release in rat hippocampal slices, Neuropharmacology, 34 (1995) 141-147.
118. Descarries, L., Watkins, K.D. and Lapierre, Y., Noradrenergic axon terminals in the cerebral cortex of rat. III. Topometric ultrastructural analysis, Brain Res., 133 (1977) 197-222.
119. 3H]paroxetine binding and serotonin content of rat brain: absence of changes following antidepressant treatments, Eur. J. Pharmacol., 235 (1993) 137-142.
120. Dickinson, S.L., Gadie, B., Havler, M.E., Hunter, C. and Tulloch, I.F., Behavioral effects of idazoxan given continuously by osmotic minipump in the rat, Br.J. Pharmacol., 98 (1989) 932p.
121. Dijcks, F.A., Ruigt, G.S. and De Graaf, J.S., Antidepressants affect amine modulation of neurotransmission in the rat hippocampal slice. I. Delayed effects, Neuropharmacology, 30 (1991) 1141-1150.
122. 2 receptor activation decreases noradrenaline release in rat hippocampus in vivo, Br. J. Pharmacol., 107 (1992) 240-245.
123. 2 receptors: microdialysis studies in the awake and anaesthetized rat, Neuropharmacology, 33 (1994) 411-421.
124. 2-adrenoceptor binding in elderly depressed patients, Am. J. Psychiatry, 142 (1985) 1489-1490.
125. Doze, V.A., Cohen, G.A. and Madison, D.V., Synaptic localization of adrenergic disinhibition in the rat hippocampus, Neuron, 6 (1991) 889-900.
126. 2-agonist oxaminozoline (S3341) on firing rate of central noradrenergic and serotonergic neurons in the rat. Comparison with clonidine, Arch. Int. Physiol. Biochim., 94 (1986) 99-106.
127. Dumuis, A., Bouhelal, R., Sebben, M. and Bockaert, J., A 5-HT receptor in the central nervous system, positively coupled with adenylate cyclase, is antagonized by ICS 205930, Eur. J. Pharmacol., 146 (1988) 187-188.
128. Dumuis, A., Bouhelal, R., Sebben, M., Cory, R. and Bockaert, J., A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system, Mol. Pharmacol., 34 (1988) 880-887.
129. Dumuis, A., Sebben, M. and Bockaert, J., Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture, Mol. Pharmacol., 33 (1988) 178-186.
130. 3H] desipramine binding sites, J. Pharmacol. Exp. Ther., 248 (1989) 470-477.
131. Dyr, W., Kostowski, W., Zacharski, B. and Bidzinski, A., Differential clonidine effects on EEG following lesions of the dorsal and median raphe nuclei in rats, Pharmacol. Biochem. Behav., 19 (1983) 177-185.
132. Ebert, M.H., Baldessarini, R.J., Lipinski, L.F. and Berv, K., Effects of electroconvulsive seizures on amine metabolism in the rat brain, Arch. Gen. Psychiatry, 29 (1973) 397-401.
133. Eichenbaum, H. and Otto, T., LTP and memory: can we enhance the connection? Trends Neurosci., 16 (1993) 163-165.
134. 3H]5-hydroxytryptamine release: effects of antidepressant drugs, J. Neurochem., 46 (1986) 218-223.
135. Elmes, D.G., Jarrard, L.E. and Swart, P.D., Helplessness in hippocampectomised rats: response perseveration? Physiol. Psychol., 3 (1975) 51-55.
136. 2-receptor blockage, J. Neural Transm., 76 (1989) 91-98.
137. 2-adrenoceptor agonists on locus coeruleus firing rate and brain noradrenaline turnover in N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ)-treated rats, Naunyn-Schmiedeberg's Arch. Pharmacol., 343 (1991) 472-477.
138. Engel, J., Hanson, L.C.F. and Roos, B.-E., Effect of electroshock on 5-HT metabolism in rat brain, Psychopharmacology, 20 (1971) 197-200.
139. Ernsberger, P.R., Westbrooks, K.L., Christen, M.O. and Schafer, S.G., A second generation of centrally acting antihypertensive agents act on putative I1-imidazoline receptors, J. Cardiovasc. Pharmacol., 20 (1992) S1-S10.
140. 1A receptor binding sites following chronic treatment with ipsapirone measured by quantitative autoradiography, Synapse, 12 (1992) 75-81.
141. Fernandez-Guasti, A., Hansen, S., Archer, T. and Jonsson, G., Noradrenaline-serotonin interaction in the control of sexual behavior in the male rat: DSP4-induced noradrenaline depletion antagonizes the facilitory effect of serotonin receptor agonists, Brain Res., 377 (1985) 112-118.
142. Feuerstein, T.J., Allgaier, C. and Hertting, G., Possible involvement of protein kinase C (PKC) in the regulation of electrically evoked serotonin (5-HT) release from rabbit hippocampal slices, Eur. J. Pharmacol., 139 (1987) 267-272.
143. Feuerstein, T.J. and Hertting, G., Serotonin (5-HT) enhances hippocampal noradrenaline (NA) release: evidence for facilitatory 5-HT receptors within the CNS, Naunyn-Schmiedeberg's Arch. Pharmacol., 333 (1986) 191-197.
144. Feuerstein, T.J., Hertting, G. and Jackisch, R., Endogenous noradrenaline as modulator of hippocampal 5-HT release, Naunyn-Schmiedeberg's Arch. Pharmacol., 329 (1985) 216-221.
145. Feuerstein, T.J., Hertting, G. and Jackisch, R., Endogenous noradrenaline as modulator of hippocampal serotonin (5-HT)-release. Dual effects of yohimbine, rauwolscine and corynanthine as alpha-adrenoceptor antagonists and 5-HT-receptor agonists, Naunyn-Schmiedeberg's Arch. Pharmacol., 329 (1985) 216-221.
146. Feuerstein, T.J., Lupp, A. and Hertting, G., The serotonin (5-HT) autoreceptor in the hippocampus of the rabbit: role of 5-HT biophase concentration, Neuropharmacology, 26 (1987) 1071-1080.
147. 2 presynaptic receptor activity and catecholamine release following chronic MAO inhibition, J. Neural Transm., 32 (1990) 405-412.
148. Finberg, J.P.M. and Tal, A., Reduced peripheral presynaptic adrenoceptor sensitivity following chronic antidepressant treatment in rats, Br. J. Pharmacol., 84 (1985) 609-617.
149. Finberg, J.P.M. and Youdim, M.B.H., Selective MAO A and B inhibitors: their mechanism of action and pharmacology, Neuropharmacology, 22 (1983) 441-446.
150. 1-adrenoceptor function in rat hippocampal miniprisms after repeated antidepressant treatment, J. Neural Transm., 66 (1986) 197-208.
151. Frances, A., Manning, D., Marin, D., Kocsis, J., McKinney, K., Hall, W. and Kline, M., Relationship of anxiety and depression, Psychopharmacology, 106 Suppl. (1992) S82-S86.
152. 3H-5-HT release from slices of rat hippocampus, Eur. J. Pharmacol., 63 (1980) 179-182.
153. 3H-5-HT release form slices of the hippocampus of the rat, Eur. J. Pharmacol., 81 (1982) 97-106.
154. 2-Adrenoceptor mediated inhibition of the release of radiolabelled 5-hydroxytryptamine and noradrenaline from slices of the dorsal region of the rat brain, Naunyn-Schmiedeberg's Arch. Pharmacol., 337 (1988) 255-260.
155. 2-adrenoceptors on rat central neurons, Eur. J. Pharmacol., 105 (1984) 265-272.
156. Freund, T.F., Gulyas, A.I., Acsady, L., Gorcs, T. and Toth, K., Serotonergic control of the hippocampus via local inhibitory interneurons, Proc. Natl. Acad. Sci. USA, 87 (1990) 8501-8505.
157. Fuxe, K., The distribution of monoamine terminals in the central nervous system, Acta Physiol. Scand., 64 (Suppl. 247) (1965) 37.
158. Gage, F.H. and Springer, J.E., Behavioral assessment of norepinephrine and serotonin function and interaction in the hippocampal formation, Pharmacol. Biochem. Behav., 14 (1981) 815-821.
159. Gallager, D.W. and Bunney, W.E., Failure of chronic lithium treatment to block tricyclic antidepressant-induced 5-HT supersensitivity, Naunyn-Schmiedeberg's Arch. Pharmacol., 307 (1979) 129-133.
160. Galzin, A.M. and Langer, S.Z., Modulation of 5-HT release by presynaptic
161. 2-adrenoceptors on serotonergic nerve endings in the rat hypothalamus, J. Pharmacol. Exp. Ther., 228 (1984) 725-732.
162. 3H]hydroxytryptamine in slices of the human neocortex, J. Neurochem., 59 (1992) 1293-1301.
163. 2-adrenoceptors in major affective disorder: effect of long-term lithium carbonate treatment, Arch. Gen. Psychiatry, 43 (1986) 51-57.
164. 3H-(-)adrenaline to platelets of depressed patients with melancholia: effect of long-term clomipramine treatment, Acta Psychiatry Scand., 75 (1987) 150-157.
165. 2-adrenergic receptors in major depressive disorder, Arch. Gen. Psychiatry, 38 (1981) 1327-1333.
166. Garratt, J.C., Crespi, F., Mason, R. and Marsden, C.A., Effects of idazoxan on dorsal raphe 5-hydroxytryptamine neuronal function, Eur. J. Pharmacol., 193 (1991) 87-93.
167. Geyer, M.A. and Lee, E.H., Effects of clonidine, piperoxane and locus coeruleus lesion on the serotonergic and dopaminergic systems in raphe and caudate nucleus, Biochem. Pharmacol., 33 (1984) 3399-3404.
168. Gillespie, D.D., Manier, D.H., Sanders-Bush, E. and Sulser, F., The serotonin/norepinephrine-link in brain. II. Role of serotonin in the regulation of β-adrenoceptors in the low agonist affinity conformation, J. Pharmacol. Exp. Ther., 244 (1988) 154-159.
169. 2B-adrenoceptor subtype, Naunyn-Schmiedeberg's Arch. Pharmacol., 342 (1990) 382-386.
170. Godbout, R., Chaput, Y., Blier, P. and de Montigny, C., Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine. I. Effects of acute and long-term administration of tandospirone on serotonin neurotransmision, Neuropharmacology, 7 (1991) 679-690.
171. Goldfarb, J., Walcott, J. and Blandina, P., Serotonergic modulation of L-glutamic acid-evoked release of endogenous norepinephrine from rat hypothalamus, J. Pharmacol. Exp. Ther., 267 (1993) 45-50.
172. 2-agonist and antagonist properties of RX 781094, Eur. J. Pharmacol., 91 (1983) 101.
173. 2 receptors, Eur. J. Pharmacol., 154 (1988) 285-291.
174. 2 receptors: involvement of the prepositus hypoglossal nucleus, Neuropharmacology, 30 (1991) 1309-1318.
175. Gothert, M. and Huth, H., α-Adrenoceptor-mediated modulation of 5-HT release from rat brain cortex slices, Naunyn-Schmiedeberg's Arch. Pharmacol., 313 (1980) 21-26.
176. Gothert, M., Huth, H. and Schlicker, E., Characterization of the receptor subtype involved in α-adrenoceptor-mediated modulation of serotonin release from rat brain cortex slices, Naunyn-Schmiedeberg's Arch. Pharmacol., 317 (1981) 199-203.
177. 2-adrenoceptor-independent inhibition of noradrenaline release by imidazoline derivatives, Naunyn-Schmiedeberg's Arch. Pharmacol., 343 (1991) 271-282.
178. Gothert, M., Schlicker, E. and Kostermann, F., Relationship between transmitter uptake inhibition and effects of α-adrenoceptor agonists on serotonin and noradrenaline release in the rat brain cortex, Naunyn-Schmiedeberg's Arch. Pharmacol., 322 (1983) 121-128.
179. Graeff, F.G., Audi, E.A., Almeida, S.S., Graeff, E.O. and Hunziker, M.H., Behavioral effects of 5-HT receptor ligands in the aversive brain stimulation, elevated plus-maze and learned helplessness tests, Neurosci. Biobehav. Rev., 14 (1990) 501-506.
180. Graeff, F.G., Quintero, S. and Gray, J.A., Median raphe stimulation, hippocampal θ-rhythm and threat-induced behavioral inhibition, Physiol. Behav., 25 (1980) 253-261.
181. Graham, A.W. and Aghajanian, G.K., Effects of amphetamine on single cell activity in a catecholamine nucleus, the locus coeruleus, Nature, 234 (1971) 100-102.
182. 3H]paroxetine binding to cerebral cortical membranes of the rat, Neuropharmacology, 26 (1987) 1087-1092.
183. Gravel, P. and de Montigny, C., Noradrenergic denervation prevents sensitization of rat forebrain neurons to serotonin by tricyclic antidepressant treatment, Synapse, 1 (1987) 233-239.
184. Gray, J.A., The Neuropsychology of Anxiety: An Enquiry into the Functions of the Septo-hippocampal System, Oxford University Press, Oxford, 1987.
185. Gray, R. and Johnston, D., Noradrenaline and β-adrenoceptor agonists increase activity of voltage-dependent calcium channels in hippocampal neurons, Nature, 327 (1987) 620-622.
186. Green, A.R. and Deakin, J.F.W., Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin and dopamine mediated behaviour, Nature, 285 (1980) 232-233.
187. Green, A.R. and Grahame-Smith, D.G., (-)-Propranolol inhibits the behavioural responses of rats to increased 5-hydroxytryptamine in the central nervous system, Nature, 262 (1976) 594.
188. 3H-rauwolscine to cortical membranes, Naunyn-Schmiedeberg's Arch. Pharmacol., 328 (1985) 229-235.
189. Guimaraes, F.S., Del Bel, E.A., Padovan, C.M., Mendonca Netto, S. and Titze de Almeida, R., Hippocampal 5-HT receptors and consolidation of stressful memories, Behav. Brain Res., 58 (1993) 133-139.
190. Haas, H.L. and Konnerth, A., Histamine and noradrenaline decrease calcium-activated potassium conductance in hippocampal pyramidal cells, Nature, 302 (1983) 432-434.
191. 3 agonist 2-methyl-5-HT on the 5-HT system in the rat brain, Synapse, 20 (1995) 54-67.
192. 2-adrenoceptor antagonist mirtazapine on rat the 5-hydroxytryptamine system in the rat brain, J. Pharmacol. Exp. Ther., 277; (1996) 861-871.
193. Haigler, H.J. and Aghajanian, G.K., Peripheral serotonin antagonists: failure to antagonize serotonin in brain areas receiving a prominent serotonergic input, J. Neural Transm., 35 (1974) 157-273.
194. Hammond, D.L., Tyce, G.M. and Yaksh, T.L., Efflux of 5-HT and NA into spinal cord superfusates during stimulation of the rat medulla, J. Physiol., 359 (1985) 151-162.
195. Haring, J.H. and Davis, J.N., Differential distribution of locus coeruleus projections to the hippocampal formation: anatomical and biochemical evidence, Brain Res., 325 (1985) 366-369.
196. Harley, C., Milway, J.S. and Lacaille, J.C., Locus coeruleus potentiation of dentate gyrus responses: evidence for two systems, Brain Res. Bull., 22 (1989) 643-650.
197. Harley, C.W., A role for norepinephrine in arousal, emotion and learning?: limbic modulation by norepinephrine and the Kety hypothesis, Prog. Neuropsychopharmacol. Biol. Psychiatry, 11 (1987) 419-458.
198. Harley, C.W. and Milway, J.S., Glutamate ejection in the locus coeruleus enhances the perforant path-evoked population spike in the dentate gyrus, Exp. Brain Res., 63 (1986) 143-150.
199. Hausdorff, W.P., Caron, M.G. and Lefkowitz, R.J., Turning off the signal: desensitization of β-adrenergic receptor function, FASEB J., 4 (1990) 2881-2889.
200. Hauser, K., Olpe, H.R. and Jones, R.S., Trimipramine, a tricyclic antidepressant exerting atypical actions on the central noradrenergic system, Eur. J. Pharmacol., 111 (1985) 23-30.
201. Hayakawa, H., Shimizu, M. and Yamawaki, S., The effects of electroconvulsive shock or imipramine on subtypes of α-adrenoceptors in the frontal cortex of the rat, Neuropharmacology, 31 (1992) 955-960.
202. 2-adrenoceptor-mediated responses by antidepressant treatments, Psychopharmacology, 101 (1990) 100-106.
203. 2-mediated head-twitch responses in mice: possible implications for the actions of antidepressant drugs, Psychopharmacology, 89 (1986) 414-420.
204. 2-adrenoceptors respectively, Br. J. Pharmacol., 95 (1988) 781p.
205. 2-adrenoceptor function in the brain: rapid down-regulation by sibutramine hydrochloride, Psychopharmacology, 103 (1991) 251-257.
206. 2-adrenoceptors exclusively by sibutramine hydrochloride, Psychopharmacology, 107 (1992) 497-502.
207. Hemrick-Luecke, S.K., Fuller, R.W. and Snoddy, H.D., Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice, J. Pharmacol. Exp. Ther., 269, (1994) 132-136.
208. 1A receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatments, Neuropsychopharmacology, 4 (1991) 131-144.
209. Hensler, J.G., Ordway, G.A., Gambarana, C., Areso, P. and Frazer, A., Serotonergic neurons do not influence the regulation of β-adrenoceptors induced by either desipramine or isoproterenol, J. Pharmacol. Exp. Ther., 256 (1991) 656-664.
210. Hertting, G. and Allgaier, C., Participation of protein kinase C and regulatory G proteins in modulation of the evoked noradrenaline release in brain, Cell. Mol. Neurobiol., 8 (1988) 105-114.
211. Heym, J., Trulson, M.E. and Jacobs, B.L., Effects of adrenergic drugs on raphe unit activity in freely moving cats, Eur. J. Pharmacol., 74 (1981) 117-125.
212. 2-Noradrenergic modulation of hippocampal θ-activity, Brain Res. Bull., 26 (1991) 29-36.
213. Hieble, J.P. and Ruffolo, R.R., Imidazoline receptors: historical perspective, Fund. Clin. Pharmacol., 6 (1992) 7s-13s.
214. 1A autoreceptors and α-adrenoceptors in the inhibition of 5-HT release. I. BMY7378 and prazosin, Neuropharmacology, 34 (1995) 615-620.
215. 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo, Naunyn-Schmiedeberg's Arch. Pharmacol., 338 (1988) 463-471.
216. 1B receptor agonist CP-93,129 suppresses rat hippocampal 5-HT release in vivo: comparison with RU 24969, Eur. J. Pharmacol., 209 (1991) 249-252.
217. 2-adrenoceptors in rat brain. In S.Z. Langer A.M. Galzin and J. Costentin (Eds.), Presynaptic Receptors and Neuronal Transporters, Pergamon, Oxford, 1991, pp. 39-42.
218. Hopkins, W.F. and Johnston, D., Frequency-dependent noradrenergic modulation of long-term potentiation in the hippocampus, Science, 226 (1984) 350-351.
219. Hopkins, W.F. and Johnston, D., Noradrenergic enhancement of long-term potentiation at mossy fiber synapses in the hippocampus, J. Neurophysiol., 59 (1988) 667-687.
220. 1-adrenergic receptor mRNA and ligand binding by antidepressant treatments and norepinephrine depletion in rat frontal cortex, J. Neurochem., 60 (1993) 1335-1343.
221. Hotta, I. and Yamawaki, S., Possible involvement of presynaptic 5-HT autoreceptors in effect of lithium on 5-HT release in hippocampus of rat, Neuropharmacology, 27 (1988) 987-992.
222. 1B recognition sites, Brain Res., 376 (1986) 85-96.
223. 2 receptors in rat brain: an autoradiographic study, Synapse, 14 (1993) 324-331.
224. Hsiao, J.K., Ågren, H., Bartko, J.J., Rudorfer, M.V., Linnoila, M. and Potter, W.Z., Monoamine neurotransmitter interactions and the prediction of antidepressant response, Arch. Gen. Psychiatry, 44 (1987) 1078-1083.
225. Huang, Y.H., Maas, J.W. and Hu, G.H., The time course of noradrenergic pre- and postsynaptic activity during chronic desipramine treatment, Eur. J. Pharmacol., 68 (1980) 41-47.
226. Hyttel, J., Overo, K.F. and Arnt, J., Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-up-take inhibitor, citalopram, Psychopharmacology, 83 (1984) 20-27.
227. B-induced hyperpolarization of rat dorsal raphe neurons, Brain Res., 459 (1988) 27-36.
228. 2-Adrenoceptor mediated inhibition of exocytotic noradrenaline release in the absence of extracellular Calcium, Eur. J. Pharmacol. - Mol. Pharmacol., 226 (1992) 245-252.
229. Jackisch, R., Werle, E. and Hertting, G., Identification of mechanisms involved in the modulation of release of noradrenaline in the hippocampus of the rabbit in vitro, Neuropharmacology, 23 (1984) 1363-1371.
230. Jacobs, B.L., Abercrombie, E.D., Fornal, C.A., Levine, E.S., Morilak, D.A. and Stafford, I.L., Single-unit and physiological analyses of brain norepinephrine function in behaving animals, Prog. Brain Res., 88 (1991) 159-165.
231. Jacobs, B.L. and Azmitia, E.C., Structure and function of the brain serotonin system, Physiol. Rev., 72 (1992) 165-229.
232. Jacobs, B.L., Trimbach, C., Eubanks, E.E. and Trulson, M., Hippocampal mediation of raphe lesion- and PCPA-induced hyperactivity in the rat, Brain Res., 94 (1975) 253-261.
233. Jacobs, B.L., Wilkinson, L.O. and Casimir, A.F., The role of brain serotonin: a neurophysiologic perspective, Neuropsychopharmacology, 3 (1990) 473-479.
234. 1 of the hippocampus in vitro, Brain Res., 197 (1980) 83-94.
235. Janowsky, D.S., Steranka, L.R., Gillespie, D.D. and Sulser, F., Role of neuronal signal input in the down-regulation of central noradrenergic receptor function by antidepressant drugs, J. Neurochem., 39 (1982) 290-292.
236. 1 hippocampal area after adrenalectomy, Brain Res., 550 (1991) 347-352.
237. Joels, M. and de Kloet, E.R., Effect of corticosteroid hormones on electrical activity in rat hippocampus, J. Steroid Biochem. Molec. Biol., 40 (1991) 83-86.
238. 1 neurons, J. Neurosci., 11 (1991) 2288-2294.
239. Johnson, J., Sherman, A., Petty, F., Taylor, D. and Henn, F., Receptor changes in learned helplessness, Soc. Neurosci. Abstr., 8 (1982) 392.
240. 1A receptors in rats treated chronically with a novel antidepressant, cericlamine, J. Pharmacol. Exp. Ther., 268 (1994) 1432-1443.
241. Jones, B.E. and Moore, R.Y., Ascending projections of the locus coeruleus in the rat. II. Autoradiographic study, Brain Res., 127 (1977) 23-53.
242. Kahn, R.J., McNair, D.M., Lipman, R.S., Covi, L., Rickels, K., Downing, R., Fisher, S. and Frankenthaler, L.M., Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients, Arch. Gen. Psychiatry, 43 (1986) 79-85.
243. Kahn, R.S., van Praag, H.M., Wetzler, S., Asnis, G.M. and Barr, G., Serotonin and anxiety revisited, Biol. Psychiatry, 23 (1988) 189-208.
244. Kalen, P., Rosegren, E., Lindvall, O. and Bjorklund, A., Hippocampal noradrenaline and serotonin release over 24 hours as measured by the dialysis technique in freely moving rats: correlation to behavioural activity state, effect of handling and tail-pinch, Eur. J. Neurosci., 1 (1989) 181-188.
245. Kellar, K.J. and Bergstrom, D.A., Electroconvulsive shock: effects on biochemical correlates of neurotransmitter receptors in rat brain, Neuropharmacology, 22 (1983) 401-406.
246. Kim, J.J. and Fanselow, M.S., Modality-Specific retrograde amnesia of fear, Science, 256 (1992) 675-677.
247. Klancnik, J. and Phillips, A.G., Modulation of synaptic plasticity in the dentate gyrus of the rat by electrical stimulation of the median raphe nucleus, Brain Res., 557 (1991) 236-240.
248. Kolasa, K., Song, L. and Jope, R.S., Adrenalectomy increases phosphoinositide hydrolysis induced by norepinephrine or excitatory amino acids in rat hippocampal slices, Brain Res., 579 (1992) 128-134.
249. Koslow, J.H., Maas, J.W., Bowden, C.L., Davis, J.M., Hanin, I. and Javaid, J., CSF and urinary biogenic amines and metabolites in depression and mania, Arch. Gen. Psychiatry, 40 (1983) 999-1010.
250. 2-adrenoceptors in the locus coeruleus and its projection fields in rat brain determined by quantitative autoradiography, Neuropsychopharmacology, 8 (1993) 57-65.
251. Koyama, Y. and Kayama, Y., Mutual interactions among cholinergic, noradrenergic and serotonergic neurons studied by ionophoresis of these transmitters in rat brainstem nuclei, Neuroscience, 55 (1993) 1117-1126.
252. Kreiss, D.S. and Lucki, I., Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo, J. Pharmacol. Exp. Ther., 274 (1995) 866-876.
253. L'Heureux, R., Dennis, T., Curet, O. and Scatton, B., Measurement of endogenous noradrenaline release in the rat cerebral cortex in vivo by transcortical dialysis: effects of drugs affecting noradrenergic transmission, J. Neurochem., 46 (1986) 1794-1801.
254. Laborit, H., Les Comportements. Biologie, Physiologie, Pharmacologie, Masson, Paris, 1973.
255. Lacaille, J.C. and Harley, C.W., The action of norepinephrine in the dentate gyrus: beta-mediated facilitation of evoked potentials in vitro, Brain Res., 358 (1985) 210-220.
256. Lacroix, D., Blier, P., Curet, O. and de Montigny, C., Effects of long-term desipramine administration on noradrenergic neurotransmission reuptake: electrophysiological studies in the rat brain, J. Pharmacol. Exp. Ther., 257 (1991) 1081-1090.
257. Lake, C.R., Pickar, D., Ziegler, M., Lipper, S., Slater, S. and Murphy, D.L., High plasma norepinephrine levels in patients with major affective disorder, Am. J. Psychiatry, 139 (1982) 1315-1318.
258. Lanfumey, L. and Adrien, J., Adaptive changes of β-adrenergic receptors after neonatal locus coeruleus lesion: regulation of serotoninergic unit activity, Synapse, 2 (1988) 644-649.
259. Langmoen, I.A., Segal, M. and Andersen, P., Mechanisms of norepinephrine actions on hippocampal pyramidal cells in vitro, Brain Res., 208 (1981) 349-362.
260. Lapin, I.P. and Oxenkrug, G.F., Intensification of central serotonergic processes as a possible determinant of the thymoleptic effect, Lancet, 1 (1969) 132-136.
261. LeDoux, J.E., Emotional memory systems in the brain, Behav. Brain Res., 58 (1993) 69-79.
262. Lee, E.H. and Ma, Y.L., Amphetamine enhances memory retention and facilitates norepinephrine release from the hippocampus in rats, Brain Res. Bull., 37 (1995) 411-416.
263. Leger, L. and Descarries, L., Serotonin nerve terminals in the locus coeruleus of adult rat: a radioautographic study, Brain Res., 145 (1978) 1-13.
264. Lesch, K-P. and Manji, H.K., Signal-transducing G proteins and antidepressant drugs: evidence for modulation of a subunit gene expression in rat brain, Biol. Psychiatry, 32 (1992) 549-579.
265. Lesch, K.P., Aulakh, C.S., Wolozin, B.J., Tolliver, T.J., Hill, J.L. and Murphy, D.L., Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants, Mol. Brain Res., 17 (1993) 31-35.
266. 1 region of the rat: inhibition and disinhibition, Can. J. Physiol. Pharmacol., 66 (1988) 814-819.
267. Li, G., Regunathan, S., Barrow, C.J., Eshraghi, J., Cooper, R. and Reis, D.J., Agmatine: an endogenous clonidine-displacing substance in the brain, Science, 263 (1994) 966-969.
268. 2-adrenoceptors at the serotonergic axons of rabbit brain cortex, Naunyn-Schmiedeberg's Arch. Pharmacol., 332 (1986) 324-331.
269. Loizou, L.A., Projections of the nucleus locus coeruleus in the albino rat, Brain Res., 15 (1969) 563-566.
270. Lucki, I. and Frazer, A., Prevention of the serotonin syndrome in rats by repeated administration of monoamine oxidase inhibitors but not tricyclic antidepressants, Psychopharmacology, 77 (1982) 205-211.
271. 1A receptors in the dorsal raphe nucleus, Eur. J. Pharmacol., 149 (1988) 9-15.
272. Maas, J.W., Biogenic amines and depression, Arch. Gen. Psychiatry, 32 (1975) 1357-1361.
273. MacRae-Deguerce, A., Berod, B., Mermet, A., Keller, A., Chouvet, G., Joh, T. and Pujol, J., Alterations in tyrosine hydrolase activity elicited by raphe nuclei lesions in the rat locus coeruleus: evidence for the involvement of serotonin afferents, Brain Res., 235 (1982) 285-301.
274. Madison, D.V. and Nicoll, R.A., Noradrenaline blocks accommodation of pyramidal cell discharge in the hippocampus, Nature, 299 (1982) 636-638.
275. Madison, D.V. and Nicoll, R.A., Cyclic adenosine 3′,5′-monophosphate mediates β-receptor actions of noradrenaline in rat hippocampal pyramidal cells, J. Physiol., 372 (1986) 245-259.
276. 1 pyramidal neurones, in vitro, J. Physiol., 372 (1986) 221-244.
277. Madison, D.V. and Nicoll, R.A., Norepinephrine decreases synaptic inhibition in the rat hippocampus, Brain Res., 442 (1988) 131-138.
278. Mamounas, L.A., Mullen, C.A., O'Hearn, E. and Molliver, M.E., Dual serotonergic projections to forebrain in the rat: morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives, J. Comp. Neurol., 314 (1991) 558-586.
279. Manier, D.H., Gillespie, D.D., Steranka, L.R. and Sulser, F., A pivotal role for serotonin in the down-regulation of β-adrenoceptors by antidepressants: reversibility of the action of p-chlorophenylalanine, Experientia, 40 (1984) 1223-1226.
280. Manier, D.H., Gillespie, D.D. and Sulser, F., Dual aminergic regulation of central beta adrenoceptors. Effect of 'atypical' antidepressants and 5-hydroxytryptophan, Neuropsychopharmacology, 2 (1989) 89-95.
281. Marciani, M.G., Calabresi, P., Stanzione, P. and Bernardi, G., Dopaminergic and noradrenergic responses in the hippocampal slice preparation. Evidence for different receptors, Neuropharmacology, 23 (1984) 303-307.
282. Markstein, R., Digges, K., Marshall, N.R. and Starke, K., Forskolin and the release of noradrenaline in cerebrocortical slices, Naunyn-Schmiedeberg's Arch. Pharmacol., 325 (1984) 17-24.
283. 3 receptors in the control of 5-HT release in rat hippocampus in vivo, Br. J. Pharmacol., 106 (1992) 139-142.
284. 2-antagonists in the locus ceruleus, dorsal raphe and dorsal lateral geniculate nuclei: an electrophysiological study, J. Pharmacol. Exp. Ther., 222 (1982) 287-293.
285. Masuko, S., Nakajima, Y., Nakajima, S. and Yamaguchi, K., Noradrenergic neurons from the locus coeruleus in dissociated cell culture: culture methods, morphology, and electrophysiology, J. Neurosci., 6 (1986) 3229-3241.
286. 2-adrenoceptor subtyptes, Naunyn-Schmiedeberg's Arch. Pharmacol., 345 (1992) 410-416.
287. 2-adrenoceptors located on serotonergic nerve terminals, Naunyn-Schmiedeberg's Arch. Pharmacol., 320 (1982) 272-274.
288. 2-Adrenoceptors in rat hypothalamus and cerebral cortex: functional evidence for pharmacologically distinct subpopulations, Eur. J. Pharmacol., 116 (1985) 335-339.
289. Maura, G., Ulivi, M. and Raiteri, M., (-)-Propranolol and (±)-cyanopindolol are mixed agonists-antagonists at serotonin autoreceptors in the hippocampus of the rat brain, Neuropharmacology, 26 (1987) 713-717.
290. 2-adrenoceptor function, J. Pharmacol. Sci., 81 (1992) 832-835.
291. McMillen, B.A., Warnack, W., German, D.C. and Shore, P.A., Effects of chronic desipramine treatment on rat brain noradrenergic responses to α-adrenergic drugs, Eur. J. Pharmacol., 61 (1980) 239-246.
292. McNaughton, N., James, D.T.D., Stewart, J., Gray, J.A., Valero, I. and Drewnowski, A., Septal driving of hippocampal θ-rhythm as a function of frequency in the male rat: effects of drugs, Neuroscience, 2 (1977) 1019-1027.
293. McRae-Degueurce, A., Léger, L., Wiklund, L. and Pujol, J.F., Functional recuperation of the serotonergic innervation in the rat locus coeruleus, J. Physiol. (Paris), 77 (1981) 389-392.
294. 2-Adrenoceptors in the brain of suicide victims: increased receptor density associated with major depression, Biol. Psychiatry, 31 (1992) 471-490.
295. Melia, K.R., Rasmussen, K., Terwilliger, R.Z., Haycock, J.W., Nestler, E.J. and Duman, R.S., Coordinate regulation of the cyclic AMP system with firing rate and expression of tyrosine hydroxylase in the rat locus coeruleus: effects of chronic stress and drug treatments, J. Neurochem., 58 (1992) 494-502.
296. 1B receptors in the dorsal hippocampus and cortex of the rat, Neuroendocrinology, 55 (1992) 444-450.
297. 1-Adrenoceptor-mediated responses in the lateral geniculate nucleus are enhanced by chronic antidepressant treatment, Eur. J. Pharmacol., 74 (1981) 27-35.
298. 1-adrenoceptors, Eur. J. Pharmacol., 87 (1983) 35-41.
299. Menkes, D.B., Aghajanian, G.K. and McCall, R.B., Chronic antidepressant treatment enhances α-adrenergic and serotonergic responses in the facial nucleus, Life Sci., 27 (1980) 45-55.
300. Middlemiss, D.N., Blockade of the central 5-HT autoreceptor by β-adrenoceptor antagonists, Eur. J. Pharmacol., 120 (1986) 51-56.
301. Middlemiss, D.N., Bremer, M.E. and Smith, S.M., A pharmacological analysis of the 5-HT receptor mediating inhibition of 5-HT release in the guinea-pig frontal cortex, Eur. J. Pharmacol., 157 (1988) 101-107.
302. 3 sites in rat brain, Jpn. J. Pharmacol., 47 (1988) 107-113.
303. 1B receptors on the sympathetic nerve terminals of the rat inferior vena cava, Naunyn-Schmiedeberg's Arch. Pharmacol., 341 (1990) 391-397.
304. 1A Binding Site, Master thesis at McGill University, Montreal, 1990,
305. 2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus, Naunyn-Schmiedeberg's Arch. Pharmacol., 347 (1993) 266-272.
306. 3H]noradrenaline in rat brain limbic structures, Eur. J. Pharmacol., 256 (1994) 269-279.
307. 3H]noradrenaline in the rat hippocampus, Eur. J. Pharmacol., 271 (1994) 121-129.
308. 2-adrenoceptors modulating serotonin neurotransmission, J. Pharmacol. Exp. Ther., 269 (1994) 1152-1159.
309. 2-adrenoceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentration, Neuropsychopharmacology, 10 (1994) 41-51.
310. Mongeau, R., Weiss, M., Blier, P. and de Montigny, C., Effects of acute, short- and long-term administration of milnacipran on locus coeruleus noradrenergic and dorsal raphe serotonergic neurons (submitted) (1996)
311. 1A receptor in rat hippocampus, Brain Res., 590 (1992) 229-238.
312. Moore, R.Y., Halaris, A.E. and Jones, B.E., Serotonin neurons of the midbrain raphe: ascending projections, J. Comp. Neurol., 180 (1978) 417-430.
313. Moret, C. and Briley, M., Serotonin autoreceptor subsensitivity and antidepressant activity, Eur. J. Pharmacol., 180 (1990) 351-356.
314. Morin, D., Sapena, R., Zini, R. and Tillement, J.P., Serotonin enhances the β-adrenergic response in rat brain cortical slices, Eur. J. Pharmacol., 225 (1992) 273.
315. Mueller, A.L., Hoffer, B.J. and Dunwiddie, T.V., Noradrenergic responses in rat hippocampus: evidence for mediation by α- and β-receptors in the in vitro slice, Brain Res., 214 (1981) 113-126.
316. Mueller, A.L., Kirk, K.L., Hoffer, B.J. and Dunwiddie, T.V., Noradrenergic responses in rat hippocampus: electrophysiological actions of direct- and indirect-acting sympathomimetics in the in vitro slice, J. Pharmacol. Exp. Ther., 223 (1982) 599-605.
317. Mueller, A.L., Palmer, M.R., Hoffer, B.J. and Dunwiddie, T.V., Hippocampal noradrenergic responses in vivo and in vitro. Characterization of α and β components, Naunyn-Schmiedeberg's Arch. Pharmacol., 318 (1982) 259-266.
318. Murugaiah, K.D. and O'Donnell, J.M., Facilitation of noradrenaline release from rat brain slices by β-adrenoceptors, Naunyn-Schmiedebergs Arch. Pharmacol., 351 (1995) 483-490.
319. Muth, E.A., Haskins, J.T., Moyer, J.A., Husbands, G.E., Nielsen, S.T. and Sigg, E.B., Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethylcyclohexanol derivative, Biochem. Pharmacol., 35 (1986) 4493-4497.
320. 1-receptors, Neuropharmacology, 27 (1988) 391-398.
321. Nelson, J.C., Mazure, C.M., Bowers, M.B. and Jatlow, P.I., A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression, Arch. Gen. Psychiatry, 48 (1991) 303-307.
322. Nestler, E.J., McMahon, A., Sabban, E.L., Tallman, J.F. and Duman, R.S., Chronic antidepressant administration decreases the expression of tyrosine hydroxylase in the rat locus coeruleus, Proc. Natl. Acad. Sci. USA, 87 (1990) 7522-7526.
323. Newman, M.E., Drummer, D. and Lerer, B., Single and combined effects of desipramine and lithium on serotonergic receptor number and secod messenger function in rat brain, J. Pharmacol. Exp. Ther., 260 (1990) 16-20.
324. Newman, M.E. and Lerer, B., Chronic electroconvulsive shock and desipramine reduce the degree of inhibition by 5-HT and carbachol of forskolin-stimulated adenylate cyclase in rat hippocampal membranes, Eur. J. Pharmacol., 148 (1988) 257-260.
325. Newman, M.E. and Lerer, B., Modulation of second messenger function in rat brain by in vivo alteration of receptor sensitivity: relevance to the mechanism of action of electroconvulsive therapy and antidepressants, Prog. Neuropsychopharmacol. Biol. Psychiatry, 13 (1989) 1-30.
326. Newman, M.E., Miskin, I. and Lerer, B., Effects of single and repeated electroconvulsive shock administration on inositol phosphate accumulation in rat brain slices, J. Neurochem., 49 (1987) 19-23.
327. 1A agonist and antidepressants, J. Pharmacol. Exp. Ther., 260 (1992) 16-20.
328. Nichols, A.J., α-Adrenoceptor signal transduction mechanism. In R.R. Ruffolo (Ed.), α-Adrenoceptors: Molecular Biology, Biochemistry and Pharmacology. Progress in Basic Clinical Pharmacology, Basel and Krager, 1991, pp. 44-74.
329. Nisenbaum, L.K., Zigmond, M.J., Sved, A.F. and Abercrombie, E.D., Prior exposure to chronic stress results in enhanced synthesis and release of hippocampal norepinephrine in response to a novel stressor, J. Neurosci., 11 (1991) 1478-1484.
330. Nishikawa, T., Tanaka, M., Tsuda, A., Khono, Y. and Nagasaki, N., Serotonergic-catecholaminergic interactions and footshock-induced jumping behavior in rats, Eur. J. Pharmacol., 94 (1983) 53.
331. 3H]prazosin binding to different rat brain structures, J. Neural Transm., 71 (1988) 57-64.
332. 1A-mediated inhibition of forskolin-stimulated adenylate cyclase activity in the hippocampal membranes from rats chronically treated with lithium or antidepressants, J. Neural Transm. - Gen. Sect., 86 (1991) 85-96.
333. Oleskevich, S. and Descarries, L., Quantified distribution of the serotonin innervation in adult rat hippocampus, Neuroscience, 34 (1990) 19-33.
334. Oleskevich, S., Descarries, L. and Lacaille, J.C., Quantified distribution of the noradrenaline innervation in the hippocampus of adult rat, J. Neurosci., 9 (1989) 3803-3815.
335. Olpe, H.R., Schellenberg, A. and Jones, R.S., The sensitivity of hippocampal pyramidal neurons to serotonin in vitro: effect of prolonged treatment with clorgyline or clomipramine, J. Neural Transm., 60 (1984) 265-271.
336. Ortmann, R., Martin, S., Radeke, E. and Delini-Stula, A., Interaction of β-adrenoceptor agonists with the serotonergic system in rat brain. A behavioral study using the L-5-HTP syndrome, Naunyn-Schmiedeberg's Arch. Pharmacol., 316 (1981) 225-230.
337. 2-antagonism increases norepinephrine, blocks GH release and is antidepressant, Biol. Psychiatry, 25 (1989) 197A.
338. 3 neurons in hippocampal slices, Brain Res., 253 (1982) 173-183.
339. s to the catalytic moiety of adenylylcyclase in a manner similar to that seen with chronic antidepressant drugs, J. Neurochem., 56 (1991) 330-338.
340. Ozawa, H., Rasenick, M.M. and Saito, T., Effect of chronic antidepressant administration on β-adrenergic receptor GTP binding protein adenylate cyclase coupling, Biogenic Amines, 7 (1990) 535-546.
341. Palfreyman, M.G., Mir, A.K., Kubina, M., Middlemiss, D.N., Richards, M., Tricklebank, M.D. and Fozard, J.R., Monoamine receptor sensitivity changes following chronic administration of MDL 72394, a site-directed inhibitor of monoamine oxidase, Eur. J. Pharmacol., 130 (1986) 73-89.
342. Pang, K. and Rose, G.M., Differential effects of norepinephrine on hippocampal complex-spike and θ-neurons, Brain Res., 425 (1987) 146-158.
343. Passarelli, F., Costa, T. and Almeida, O.F., Pertussis toxin inactivates the presynaptic serotonin autoreceptor in the hippocampus, Eur. J. Pharmacol., 155 (1988) 297-299.
344. Paton, W.D.M. and Vizi, E.S., The inhibitory action of noradrenaline and acetylcholine output by guinea-pig longitudinal muscle strip, Br. J. Pharmacol., 35 (1969) 10-28.
345. Paul, I.A., Duncan, G.E., Powell, K.R., Mueller, R.A., Hong, J.S. and Breese, G.R., Regionally specific neural adaptation of β-adrenergic and 5-hydroxytryptamine2 receptors after antidepressant administration in the forced swim test and after chronic antidepressant drug treatment, J. Pharmacol. Exp. Ther., 246 (1988) 956-962.
346. 1A selective drugs, Neuropharmacology, 26 (1987) 139-146.
347. Peroutka, S.J. and Snyder, S.H., Long-term antidepressant treatment decreases spiroperidol-labelled serotonin receptor binding, Science, 210 (1980) 88-90.
348. 3 receptors, Trends Pharmacol. Sci., 13 (1992) 391-397.
349. Phillips, R.G. and LeDoux, J.E., Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning, Behav. Neurosci., 106 (1992) 274-285.
350. Pickel, V.M., Joh, T.H. and Reis, D.J., A serotonergic innervation of noradrenergic neurons in nucleus locus coeruleus: demonstration by immunocytochemical localization of the transmitter specific enzymes tyrosine and tryptophan hydroxylase, Brain Res., 131 (1977) 197-214.
351. Piletz, J.E., Halaris, A., Saran, A. and Marler, M.R., Desipramine lowers tritiated para-aminoclonidine binding in platelets of depressed patients, Arch. Gen. Psychiatry, 48 (1991) 813-820.
352. 2-adrenoreceptors in depressive illness, Life Sci., 39 (1986) 1589-1616.
353. 2-Adrenoceptor antagonists as antidepressants: the search for selectivity, Psychopharmacology Series, 3 (1987) 107-112.
354. Piñeyro, G., Blier, P., Dennis, T. and de Montigny, C., Desensitization of the neuronal 5-HT carrier following its long-term blockade, J. Neurosci., 14 (1994) 3036-3047.
355. 1D receptors, Soc. Neurosci. Abstr., 19 (1993)
356. 1D receptors in the rat brain, Synapse, 22 (1996) 54-62.
357. Plaznik, A., Danysz, W., Kostowski, W., Bidzinski, A. and Hauptmann, M., Interaction between noradrenergic and serotonergic brain systems as evidenced by microinjections of adrenergic agonists and antagonists into the median raphe nucleus, Pharmacol. Biochem. Behav., 19 (1983) 27-32.
358. Plaznik, A. and Kostowski, W., The involvement of serotonin and noradrenaline in the psychopathological processes of stress and depression: animal models and the effect of antidepressant drugs, Pol. J. Pharmacol. Pharm., 43 (1991) 301-332.
359. 2 receptors in rat midbrain, Eur. J. Pharmacol., 90 (1983) 377-384.
360. Quineaux, N., Scuvée-Moreau, J. and Dresse, A., Inhibition of in vitro and ex vivo uptake of noradrenaline and 5-hydroxytryptamine by five antidepressants; Correlation with reduction of spontaneous firing rate of central monoaminergic neurones, Naunyn-Schmiedeberg's Arch. Pharmacol., 319 (1982) 66-70.
361. 2-adrenoceptors mediating inhibition of noradrenaline and serotonin release from rat brain synaptosomes, Naunyn-Schmiedeberg's Arch. Pharmacol., 322 (1983) 180-182.
362. 2-adrenoceptors regulating central norepinephrine and serotonin release, J. Pharmacol. Exp. Ther., 224 (1983) 679-684.
363. 2-adrenoceptor-mediated inhibition of noradrenaline and 5-hydroxytryptamine release in rat hypothalamic slices, Naunyn-Schmiedeberg's Arch. Pharmacol., 340 (1989) 386-395.
364. 2 binding affinity, Eur. J. Pharmacol., 132 (1986) 79-82.
365. Rasmussen, K. and Jacobs, B., Single Unit activity of locus coeruleus neurons in the freely moving cat. - II. conditioning and pharmacologic studies, Brain Res., 371 (1986) 335-344.
366. Rasmussen, K., Morilak, D. and Jacobs, B.L., Single unit activity of locus coeruleus neurons in the freely moving cat. - I. During naturalistic behaviors and in response to simple and complex stimuli, Brain Res., 371 (1986) 324-334.
367. Rehavi, M., Ramot, O., Yavetz, B. and Sokolovsky, M., Amitriptyline: long-term treatment elevates α-adrenergic and muscarinic receptor binding in mouse brain, Brain Res., 194 (1980) 443-453.
368. Reimann, W. and Schneider, F., The serotonin receptor agonist 5-methoxy-N,N-dimethyltryptamine facilitates noradrenaline release from rat spinal cord slices and inhibits monoamine oxidase activity, Gen.Pharmacol., 24 (1993) 449-453.
369. Rickels, K., Venlafaxine: a new potent antidepressant agent with putative fast onset of action, Biol. Psychiatry, 1 (1991) 345-346.
370. 3H]dihydroalprenolol, Mol. Pharmacol., 36 (1989) 135-139.
371. Roberts, M.H.T. and Straughan, D.W., Excitation and depression of cortical neurones by 5-hydroxytryptamine, J. Physiol., 193 (1967) 269-294.
372. 1A partial agonists, buspirone and gepirone, in the treatment of depression, Clin. Neuropharmacol., 13 (suppl. 2) (1990) 228-229.
373. Rogawski, M.A. and Aghajanian, G.K., Serotonin autoreceptors on dorsal raphe neurons: structure-activity relationships of tryptamine analogs, J. Neurosci., 1 (1981) 1148-1154.
374. 1 hippocampal neurons in vitro, Neuroscience, 26 (1988) 69-81.
375. 1 region of rat hippocampus in vitro, J. Physiol., 441 (1991) 121-136.
376. Rose, A., McCulloch, M.W., Sarantos-Laska, C. and Rand, M.J., Effects of mianserin on noradrenergic mechanisms, J. Psychiatry Res., 18 (1984) 79-88.
377. 1C serotonin receptor levels. Methodology and mechanisms, Neuropsychopharmacology, 3 (1990) 427-433.
378. 1-Adrenoceptor antagonists differentially control serotonin release in the hippocampus and striatum: a microdialysis study, Eur. J. Pharmacol., 261 (1994) 59-64.
379. Rowan, M.J. and Anwyl, R., The effect of prolonged treatment with tricyclic antidepressants on the actions of 5-hydroxytryptamine in the hippocampal slice of the rat, Neuropharmacology, 24 (1985) 131-137.
380. 4 receptor colocalization on hippocampal pyramidal cells, Neuropharmacology, 33 (1994) 551-557.
381. Rudorfer, M.V. and Potter, W.Z., Antidepressants: a comparative review of the clinical pharmacology and therapeutic use of the newer versus the older drugs, Drugs, 37 (1989) 713-738.
382. 2-Modulation of type 1 and type 2 hippocampal θ in the freely moving rat, Brain Res. Bull., 31 (1993) 437-442.
383. Sakai, K., Salvert, D., Touret, M. and Jouvet, M., Afferent connections of the raphe dorsalis in the cat as visualized by the horseradish peroxidase technique, Brain Res., 137 (1977) 11-35.
384. Sanders-Bush, E. and Sulser, F., Serotonin/norepinephrine receptor interactions: sensitivity changes after antidepressants and lesions. In K. Fuxe and L.F. Agnati (Eds.), Receptor-Receptor Interactions: A New Intramembrane Integrative Mechanism, Plenum Press, New York/London, 1986, pp. 387.
385. Sanghera, M.K., Coke, J.A., Williams, H.L. and McMillen, B.A., Ipsapirone and 1-(2-pyrimidinyl)-piperazine increase rat locus coeruleus noradrenergic activity, Brain Res. Bull., 24 (1990) 17-22.
386. Sanghera, M.K. and German, D.C., The effects of benzodiazepine and non-benzodiazepine anxiolytics on locus coeruleus unit activity, J. Neural Transm., 2852 (1983) 267-279.
387. Sapolsky, R.M. and Plotsky, P.M., Hypercortisolism and its possible neural bases, Biol. Psychiatry, 27 (1990) 937-952.
388. Sara, S.J. and Bergis, O., Enhancement of excitability and inhibitory processes in hippocampal dentate gyrus by noradrenaline: a pharmacological study in awake, freely moving rats, Neurosci. Lett., 126 (1991) 1-5.
389. 3H]serotonin binding sites in rat brain, J. Pharmacol. Exp. Ther., 168 (1980) 297-304.
390. Schechter, L.E., Bolanos, F.J., Gozlan, H., Lanfumey, L., Haj-Dahmane, S., Laporte, A.M., Fattaccini, C.M. and Hamon, M., Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies, J. Pharmacol. Exp. Ther., 255 (1990) 1335-1347.
391. Schildkraut, J.J., The catecholamine hypothesis of affective disorders: a review of supporting evidence, Am. J. Psychiatry, 122 (1965) 509-522.
392. 2-adrenoceptors, Naunyn-Schmiedeberg's Arch. Pharmacol., 336 (1987) 251-256.
393. Schlicker, E., Gothert, M. and Hillenbrand, K., Cyanopindolol is a highly potent and selective antagonist at the presynaptic serotonin autoreceptor in the rat brain cortex, Naunyn-Schmiedeberg's Arch. Pharmacol., 331 (1985) 398-401.
394. Schlicker, E., Gothert, M., Kostermann, F. and Clausing, R., Effects of α-adrenoceptor antagonists on the release of serotonin and noradrenaline from rat brain cortex slices. Influence of noradrenaline uptake inhibition and determination of pA2 values, Naunyn-Schmiedeberg's Arch. Pharmacol., 323 (1983) 106-113.
395. Schlicker, E., Göthert, M., Köstermann, F. and Clausing, R., Effects of α-adrenoceptor antagonists on the release of serotonin and noradrenaline from rat brain cortex slices, Naunyn-Schmiedeberg's Arch. Pharmacol., 323 (1983) 106-113.
396. 2-adrenoceptors in the mouse brain cortex, Naunyn-Schmiedeberg's Arch. Pharmacol., 349 (1994) 20-24.
397. 3H-5-hydroxytryptamine release from rat brain slices and its presynaptic α-adrenergic modulation after long-term desipramine pretreatment, Naunyn-Schmiedeberg's Arch. Pharmacol., 318 (1982) 173-180.
398. 2-adrenergic modulation: a study on the possible role of cAMP, Naunyn-Schmiedeberg's Arch. Pharmacol., 323 (1983) 188-192.
399. 2 and β-adrenergic receptors, Neuropharmacology, 25 (1986) 1301-1306.
400. Scuvée-Moreau, J., Giesbers, I. and Dresse, A., Electrophysiological and microiontophoretic studies with buspirone: influence on the firing rate of central monoaminergic neurons and their responsiveness to dopamine, clonidine or GABA, Arch. Int. Physiol. Biochim., 95 (1987) 439-446.
401. Scuvée-Moreau, J., Giesbers, I. and Dresse, A., Effect of rolipram, a phosphodiesterase inhibitor and potential antidepressant, on the firing rate of central monoaminergic neurons in the rat, Arch. Intern. Pharmacodyn. Thér., 288 (1987) 439-446.
402. Scuvée-Moreau, J.J. and Dresse, A., Effect of various antidepressant drugs on the spontaneous firing rate of locus coeruleus and dorsal raphe neurons of the rat, Eur. J. Pharmacol., 57 (1979) 219-225.
403. Segal, M., The effects of brainsteem priming stimulation on interhemispheric hippocampal responses in the awake rat, Exp. Brain Res., 28 (1977) 529-541.
404. Segal, M., Excitability changes in rat hippocampus during conditioning, Exp. Brain Res., 55 (1977) 67-73.
405. Segal, M., Serotonergic innervation of the locus coeruleus from the dorsal raphe and its action on responses to noxious stimuli, J. Physiol., 286 (1979) 401-405.
406. Segal, M., The action of serotonin in the rat hippocampal slice preparation, J. Physiol., 303 (1980) 423-439.
407. Segal, M., Norepinephrine modulates reactivity of hippocampal cells to chemical stimulation in vitro, Exp. Neurol., 77 (1982) 86-93.
408. Segal, M. and Bloom, F.E., The action of norepinephrine in the rat hippocampus. II. Activation of the input pathway, Brain Res., 72 (1974) 99-114.
409. Segal, M. and Bloom, F.E., The action of norepinephrine in the rat hippocampus. IV. The effects of locus coeruleus stimulation on evoked hippocampal unit activity, Brain Res., 107 (1976) 513-525.
410. Segal, M., Markram, H. and Richter-Levin, G., Actions of norepinephrine in the rat hippocampus, Prog. Brain Res., 88 (1991) 323-330.
411. Seligman, M.E.P., Helplesness: On Depression, Development and Death, Freeman, San Francisco, 1975.
412. 1A autoreceptor, J. Neurosci. Methods, 34 (1990) 83-90.
413. Shenker, A., Maayani, S., Weinstein, H. and Green, J.P., Pharmacological characterization of two 5-hydroxytryptamine receptors coupled to adenylate cyclase in guinea pig hippocampal membranes, Mol. Pharmacol., 31 (1987) 357-367.
414. Sherman, A.D. and Petty, F., Neurochemical basis of the action of antidepressants on learned helplessness, Behav. Neural Biol., 30 (1980) 119-134.
415. Shopsin, B., Cassano, G.B. and Conti, L., An overview of new 'second generation' antidepressant compounds: research and treatment implications. In S.J. Enna and. et (Eds.), Antidepressants: Neurochemical, Behavioral, and Clinical Perspectives, Raven, New York, 1981, pp. 219.
416. Shopsin, B., Friedman, E. and Gershon, S., Parachlorophenylalanine reversal of tranylcypromine effects in depressed patients, Arch. Gen. Psychiatry, 33 (1976) 811-819.
417. Shopsin, B., Gershon, S. and Goldstein, M., The use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients, Psychopharmacol. Commun., 1 (1975) 239-249.
418. Siever, L.J. and Davis, K.L., Overview: toward a dysregulation hypothesis of depression, Am. J. Psychiatry, 142 (1985) 1017- 1031.
419. Sladek, J. and Walker, P., Serotonin-containing neuronal perikarya in the primate locus coeruleus and subcoeruleus nuclei, Brain Res., 134 (1977) 359-366.
420. 1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase, Eur. J. Pharmacol., 154 (1988) 255-261.
421. 2- Adrenoceptors in rat brain are decreased after long-term tricyclic antidepressant drug treatment, Brain Res., 210 (1981) 413-418.
422. Soubrie, P., Martin, P., el Mestikawy, S. and Hamon, M., Delayed behavioral response to antidepressant drugs following selective damage to the hippocampal noradrenergic innervation in rats, Brain Res., 437 (1987) 323-331.
423. 1A agonists, Eur. J. Pharmacol., 128 (1986) 295-298.
424. 1B agonists, Synapse, 1 (1987) 3-9.
425. 2- and β- adrenoceptors in different regions of rat brain, Neuroscience, 8 (1983) 161-164.
426. 2- and β-adrenoceptors in different regions of rat brain, Neuroscience, 7 (1982) 1753-1757.
427. 2- and β-adrenoceptors in different regions of rat brain, Neuroscience, 8 (1983) 161-164.
428. Stanton, P.K. and Heinemann, U., Norepinephrine enhances stimulus-evoked calcium and potassium concentration changes in dentate granule cell layer, Neurosci. Lett., 67 (1986) 233-238.
429. Stanton, P.K., Mody, I. and Heinemann, U., A role for N-methylD-aspartate receptors in norepinephrine-induced long-lasting potentiation in the dentate gyrus, Exp. Brain Res., 77 (1989) 517-530.
430. Stanton, P.K. and Sarvey, J.M., The effect of high-frequency electrical stimulation and norepinephrine on cyclic AMP levels in normal versus norepinephrine-depleted rat hippocampal slices, Brain Res., 358 (1985) 343-348.
431. Stanton, P.K. and Sarvey, J.M., Blockade of norepinephrine-induced long-lasting potentiation in the hippocampal dentate gyrus by an inhibitor of protein synthesis, Brain Res., 361 (1985) 276-283.
432. Stanton, P.K. and Sarvey, J.M., Norepinephrine regulates long-term potentiation of both the population spike and dendritic EPSP in hippocampal dentate gyrus, Brain Res. Bull., 18 (1987) 115-119.
433. Starke, K., Presynaptic α-autoreceptors, Rev. Physiol. Biochem. Pharmacol., 107 (1987) 73-145.
434. Starke, K., Göthert, M. and Kilbinger, H., Modulation of neurotransmitter release by presynaptic autoreceptors, Physiol. Rev., 69 (1989) 864-989.
435. Starke, K. and Montel, H., Involvement of α-receptors in clonidine induced inhibition of transmitter release from central monoamine neurones, Neuropharmacology, 12 (1973) 1073-1080.
436. 3 receptor antagonism on hippocampal θ-rhythm, memory, and LTP induction in the freely moving rat, J. Neurosci., 15 (1995) 2445-2452.
437. Staubli, U. and Otaky, N., Serotonin controls the magnitude of LTP induced by θ-bursts via an action on NMDA-receptor-mediated responses, Brain Res., 643 (1993) 10-16.
438. Stockmeier, C.A., Martino, A.M. and Kellar, K.J., A strong influence of serotonin axons on β-adrenergic receptors in rat brain, Science, 230 (1985) 323-325.
439. 1-adrenoceptor binding sites in rat brain, Eur. J. Pharmacol., 139 (1987) 259-266.
440. 2-adrenoceptors modulating noradrenaline release, Eur. J. Pharmacol., 213 (1992) 305-307.
441. 2-adrenoceptors, Eur. J. Pharmacol., 68 (1980) 377-380.
442. Sulser, F., Janowsky, A.J., Okada, F., Manier, D.H. and Mobley, P.L., Regulation of recognition and action function of the norepinephrine (NE) receptor-coupled adenylate cyclase system in brain: implications for the therapy of depression, Neuropharmacology, 22 (1983) 425-431.
443. Sulser, F. and Sanders Bush, E., The serotonin-norepinephrine link hypothesis of affective disorders: receptor-receptor interactions in brain, Adv. Exp. Med. Biol., 221 (1987) 489-502.
444. Svensson, T.H., Effect of chronic treatment with tricyclic antidepressant drugs on identified brain noradrenergic and serotonergic neurons, Acta Psychiatry Scand., 61 (1980) 121-131.
445. Svensson, T.H., Bunney, B.S. and Aghajanian, G.K.,Inhibition of both NA and 5-HT neurons in brain by the α-adrenergic agonist clonidine, Brain Res., 92 (1975) 291-306.
446. Svensson, T.H. and Usdin, T., Feedback Inhibition of brain noradrenaline neurons by tricyclic antidepressants: α receptor mediation, Science, 202 (1978) 1089-1091.
447. 3H-imipramine binding and plasma cortisol level in depression, Biol. Psychiatry, 26 (1989) 52-60.
448. 2-Adrenoceptor modulation of rat ventral hippocampal 5-HT release in vivo, Naunyn-Schmiedeberg's Arch. Pharmacol., 345 (1992) 137-143.
449. 2-antagonist and effective sustained antidepressant in two bipolar depressed patients, Arch. Gen. Psychiatry, 46 (1989) 958-959.
450. Tepper, J.M., Nakamura, S., Spanis, C.W., Squire, L.R., Young, S.J. and Groves, P.M., Subsensitivity of catecholaminergic neurons to direct acting agonists after single or repeated electroconvulsive shock, Biol. Psychiatry, 17 (1982) 1059-1070.
451. Thomas, D.N., Nutt, D.J. and Holman, R.B., Effects of acute and chronic electroconvulsive shock on noradrenaline release in the rat hippocampus and frontal cortex, Br. J. Pharmacol., 106 (1992) 430-434.
452. Tibirica, E., Feldman, J., Mermet, C., Gonon, F. and Bousquet, P., An imidazoline-specific mechanism for the hypotensive effect of clonidine: a study with yohimbine and idazoxan, J. Pharmacol. Exp. Ther., 256 (1991) 606-613.
453. Tollefson, G.D., Thompson, R.G., Heiligenstein, J.H., James, S., Wong, D.T., Faries, D.E. and Hyslop, D.L., Is the potent, dual uptake inhibition of norepinephrine and serotonin by LY248686 (duloxetine) associated with a more rapid and robust antidepressant response? Am. Coll. Neuropsychopharmacology, (1993)
454. Törk, I., Anatomy of the serotonergic system, Ann. NY Acad. Sci., 600 (1990) 9-35.
455. 2-autoreceptors, Naunyn-Schmiedeberg's Arch. Pharmacol., 349 (1994) 25-33.
456. Trulson, M.E. and Crisp, T., Role of norepinephrine in regulating the activity of serotonin-containing dorsal raphe neurons, Life Sci., 35 (1984) 511-515.
457. Trulson, M.E. and Jacobs, B.L., Raphe unit activity in freely moving cats: correlation with level of behavioral arousal, Brain Res., 163 (1979) 135-150.
458. 2-adrenoceptors of endogenous noradrenaline and dopamine release from slices of rat hypothalamus, Life Sci., 33 (1983) 371-376.
459. Unnerstall, J.R., Fernandez, I. and Orensanz, L.M., The alpha- adrenergic receptor: radiohistochemical analysis of functional characteristics and biochemical differences, Pharmacol. Biochem.Behav., 22 (1985) 859-874.
460. Valentino, R.J., Curtis, A.L., Parris, D.G. and Wehby, R.G., Antidepressant actions on brain noradrenergic neurons, J. Pharmacol. Exp. Ther., 253 (1990) 833-840.
461. van Praag, H.M., In search of the mode of action of antidepressants: 5-HTP/tyrosine mixtures in depression, Neuropharmacology, 22 (1983) 433-440.
462. VanderMaelen, C.P. and Aghajanian, G.K., Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices, Brain Res., 289 (1983) 109-119.
463. VanderMaelen, C.P. and Braselton, J.P., Effects of the antidepressant compound nefazodone on central monoaminergic neuronal discharge in rats, Drug Dev. Res., 25 (1992) 235-247.
464. VanderMaelen, C.P., Matheson, G.K., Wilderman, R.C. and Patterson, L.A., Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug, Eur. J. Pharmacol., 129 (1986) 123- 130.
465. Vanderwolf, C.H. and Baker, G.B., Evidence that serotonin mediates non-cholinergic neocortical low voltage fast activity, non- cholinergic hippocampal rhythmical slow activity and contributes to intelligent behavior, Brain Res., 374 (1986) 342-356.
466. Vanderwolf, C.H. and Cain, D.P., The behavioral neurobiology of learning and memory: a conceptual reorientation, Brain Res. Rev., 19 (1994) 264-297.
467. 1A-sensitive adenylylcyclase of rodent hippocampal neurons: effects of antidepressant treatments and chronic stimulation with agonists, J. Pharmacol. Exp. Ther., 257 (1991) 433-438.
468. Vetulani, J., Stawarz, R.J. and Sulser, F., Adaptative mechanisms of the noradrenergic cyclic AMP generating system in the limbic forebrain of the rat: adaptation to persistent changes in the availability of norepinephrine (NE), J. Neurochem., 27 (1976) 661-666.
469. Villani, F. and Johnston, D., Serotonin inhibits induction of long- term potentiation at commissural synapses in hippocampus, Brain Res., 606 (1993) 304-308.
470. 2-heteroreceptors in nonsynaptic modulation of transmitter release, Adv. Biosci., 82 (1992) 297-301.
471. Wang, H.Y. and Friedman, E., Chronic lithium: desensitization of autoreceptors mediating serotonin release, Psychopharmacology, 94 (1988) 312-314.
472. Wang, R.Y. and Aghajanian, G.K., Antidromically identified serotonergic neurons in the rat midbrain raphe: evidence for collateral inhibition, Brain Res., 132 (1977) 186-193.
473. Wang, R.Y. and Aghajanian, G.K., Enhanced sensitivity of amygdaloid neurons to serotonin and norepinephrine after chronic antidepressant treatment, Commun. Psychopharmacol., 4 (1980) 83- 90.
474. Wang, Y.Y. and Aghajanian, G.K., Excitation of locus coeruleus neurons by an adenosine 3′,5′-cyclic monophosphate-activated inward current: extracellular and intracellular studies in rat brain slices, Synapse, 1 (1987) 481-487.
475. 2 receptors and transport sites for serotonin, Brain Res., 615 (1993) 87-94.
476. 1A binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain, Neurochem. Int., 7 (1985) 1061-1072.
477. 1A receptors in rat brain following antidepressant drug treatment, Synapse, 4 (1989) 347-352.
478. Wilkinson, L.O. and Jacobs, B.L., Lack of response of serotonergic neurons in the dorsal raphe nucleus of freely moving cats to stressful stimuli, Exp. Neurol., 101 (1988) 445-457.
479. Williams, J.H. and Azmitia, E.G., Hippocampal serotonin reutake and nocturnal locomotor activity after microinjection of 5,7-DHT in the fornix-fimbria, Brain Res., 207 (1981) 95-107.
480. Williams, J.T., Voltage- and ligand-activated inwardly rectifying currents in dorsal raphe neurons in vitro, J. Neurosci., 8 (1988) 3499-3506.
481. 2-adrenoceptors which increase potassium conductance in rat locus coeruleus neurones, Neuroscience, 14 (1985) 95-104.
482. Willner, P., Depression: A Psychobiological Synthesis, Wiley, New York, 1985.
483. Winson, J. and Dahl, D., Action of norepinephrine in the dentate gyrus. II. Iontophoretic studies, Exp. Brain Res., 59 (1985) 497- 506.
484. Wolfe, D.B., Harden, T.K., Sporn, J.R. and Molinoff, P.B., Presynaptic modulation of β-adrenergic receptors in rat cerebral cortex after treatment with antidepressants, J. Pharmacol. Exp. Ther., 207 (1978) 305-312.
485. Wong, D.T., Bymaster, F.P., Douglas, A.M., Leroy, R.R., Krushinski, J.H. and Robertson, D.W., LY248686, a new inhibitor of serotonin and norepinephrine uptake, Neuropharmacology, 8 (1993) 23-33.
486. Wright, I.K., Upton, N. and Marsden, C.A., Effect of potential anxiolytics on extracellular 5-HT in the ventral hippocampus of rats observed on the elevated X-maze using in vivo microdialysis. In Behavioural studies, 1991.
487. 3 Receptors, Academic Press, 1992, pp. 102-127.
488. 3 receptors mediate rapid responses in cultured hippocampus and a clonal cell line, Neuron, 1 (1988) 615-621.
489. o-type GTP binding protein by tricyclic antidepressants, Neurosci. Lett., 139 (1992) 194-196.
490. Yazici, O., Aricioglu, F., Gürvit, G., Üçok, A., Tastaban, Y., Canberk,., Özgüroglu, M., Durat, T. and Sahin, D., Noradrenergic and serotoninergic depression, J. Affect. Disord., 27 (1993) 123- 129.
491. Yoshioka, M., Matsumoto, M., Togashi, H., Smith, C.B. and Saito, H., Effect of clonidine on the release of serotonin from the rat hippocampus as measured by microdialysis, Neurosci. Lett., 139 (1992) 57-60.
492. Young, E.A., Akana, S. and Dallman, M.F., Decreased sensitivity to glucocorticoid fast feedback in chronically stressed rats, Neuroendocrinology, 51 (1990) 536-542.
493. Young, E.A., Haskett, R.F., Murphy-Weinberg, V., Watson, S.J. and Akil, H., Loss of glucocorticoid fast feedback in depression, Arch. Gen. Psychiatry, 48 (1991) 693-699.
494. 1 pyramidal neurons of the hippocampus in vitro, Brain Res., 651 (1994) 337-341.
495. Zemlan, P.P. and Garver, D.L., Depression and antidepressant therapy: receptor dynamics, Prog. Neuropsychopharmacol. Biol. Psychiatry, 14 (1990) 503-523.
496. 1A receptors to the same effector systems in rat hippocampus: biochemical and electrophysiological studies, Mol. Pharmacol., 35 (1989) 484- 494.
497. 2 receptor number in brain as a probable explanation for the enhanced 5-hydroxytryptamine-mediated behaviour following repeated electroconvulsive shock administration to rats, Br. J. Pharmacol. 80 (1983) 173-177.
498. 2 receptors in rat brain, Eur. J. Pharmacol. 69 (1981) 515-518.
499. Nicoll, R.A., Madison, D.V. and Lancaster, B., oradrenergic modulation of neuronal excitability in mammalian hippocampus. In H.Y. Meltzer (Ed.), Psychopharmacology, The Third Generation of Progress, Raven Press, New York, 1987, pp. 105-112.
500. Chaput, Y., Blier, P. and de Montigny, C., Acute and long-term effects of antidepressant serotonin reuptake blockers on the efficiency of 5-HT neurotransmission: electrophysiological studies in the rat central nervous system, Adv. Biol. Psychol., 17 (1988) 1-17.